LY3471851
17287
Phase 2 small_molecule terminated
Quick answer
LY3471851 for Colitis, Ulcerative is a Phase 2 program (small_molecule) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Colitis, Ulcerative
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated